Status:

RECRUITING

Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma

Lead Sponsor:

Universitair Ziekenhuis Brussel

Conditions:

Locally Advanced Hepatocellular Carcinoma

Liver Cirrhosis

Eligibility:

All Genders

18+ years

Brief Summary

This study aims to evaluate the effectiveness and safety of Holmium-166 (Ho-166) transarterial radioembolization (TARE) for treating patients with locally advanced hepatocellular carcinoma (HCC), a co...

Detailed Description

This study investigates the use of Holmium-166 (Ho-166) transarterial radioembolization (TARE) as a treatment for patients with locally advanced hepatocellular carcinoma (HCC), a primary liver cancer....

Eligibility Criteria

Inclusion

  • aged 18 year or older
  • diagnosed with locally advanced HCC without extra-hepatic metastases
  • HCC must not be amendable to treatment by surgical resection or percutaneous radiofrequency ablation
  • after assessment by the investigator and multidisciplinary tumor board, the patient is considered suitable for protocol treatment with Holmium-166 TARE
  • ECOG performance status 0-2
  • child-Pugh A-B
  • tumor response evaluable with mRECIST criteria during follow-up

Exclusion

  • prior treatment with any of the following treatment modalities for HCC: systemic therapy, hepatic radiation therapy
  • currently enrolled in clinical studies where patient receive investigational therapeutic drug
  • metastatic disease
  • concurrent malignancy
  • active contra-indications to angiography or selective catherization (i.e. severe vascular disease or bleeding diathesis)
  • uncontrolled and/or severe comorbidities (active infection, heart failure,...) with limited estimated life expectancy
  • history of or know allergic reactions to used compounds

Key Trial Info

Start Date :

February 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06873269

Start Date

February 1 2025

End Date

February 1 2026

Last Update

March 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UZ Brussel

Brussels, Belgium

Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma | DecenTrialz